Abcentra Announces Appointment of Dr. Peter Libby as a Board Member as it Enters Orticumab’s Phase 2b Trial (FORTIFY)
LOS ANGELES, June 24, 2025 /PRNewswire/ -- Abcentra LLC (Abcentra), a [...]
Orticumab featured in Cardiovascular Business post on AI and inflammation. Read the Article.
LOS ANGELES, June 24, 2025 /PRNewswire/ -- Abcentra LLC (Abcentra), a [...]
Abcentra is excited to announce our upcoming participation in [...]
This article was originally published in Diagnostic Imaging and was written [...]
This article was originally published in Cardiovascular Business and [...]
ATLANTA, April 8, 2024 /PRNewswire/ -- Abcentra LLC, a clinical-stage [...]
Los Angeles, California (October 13, 2021) – Abcentra LLC [...]
FOR IMMEDIATE RELEASE Los Angeles, California (August 04, 2021) [...]
Los Angeles, California (August 26, 2020) – Abcentra™ LLC, [...]
FOR IMMEDIATE RELEASE LOS ANGELES, Jan. 30, 2019 /PRNewswire/ — CardioVax, a [...]
Below find a glossary of definitions for commonly used phrases [...]